PEA vs CBD - Levagen+
Cannabis contains over 500 distinct compounds, which include cannabinoids, terpenoids, flavonoids and omega fatty acids. CBD has shown to have anti-inflammatory, analgesic activity and neuroprotective properties.However, in the current state of the industry, CBD brings an inherent risk to a manufacturer. Palmitoylethanolamide (PEA) is an alternative clinically validated way to mediate the same key set of receptors. PEA is synthesized and metabolized in animal cells via a number of enzymes and exerts a multitude of physiological functions related to metabolic homeostasis. The multifaceted effects of PEA via multiple targets and the fact that PEA is a naturally occurring compound makes it a perfect candidate as an important regulator of inflammatory conditions and mediator of interactions between the nervous system, and immune system to boost the overall immunity. Research on PEA has been conducted for more than 50 years, and over 350 papers are referenced in PubMed describing the physiological properties of this endogenous modulator and its pharmacological and therapeutical profile. The administration of exogenous PEA can replenish endogenous levels and restore its anti-inflammatory and immuno-modulatory potential.
The Link Between Immune Health Benefits & Healthy, Active Lifestyles
January 11th 2024Better immune health means more healthy, active days – and who doesn’t want that? Now, we’re in an era where consumers want to be proactive about their immune health. Nutritional Outlook’s latest podcast highlights one key immune health ingredient, IMMUSE™, that brings a unique mode of action to activate pDCs (plasmacytoid dendritic cells)* — a pivotal leader within the immune system.
What Today’s Cognitive Health Consumers are Focusing On
January 10th 2024Nootropics have become a buzzword in the supplement space, and formulators are faced with a number of different ingredient options to use in their next formulation. In this podcast, Nutritional Outlook explores a clinically researched brain health ingredient, Cognizin® Citicoline, that can help supply the required nutrition that the brain needs to stay focused and alert all day long.
Balchem’s Newest Launch Optifolin⁺® Brings Innovation to the Folate Market (September 2024)
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin⁺, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
